סטאבניר

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

PRAVASTATIN SODIUM 40 MG

Available from:

BIOAVENIR LTD

ATC code:

C10AA03

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

WEST PHARMA- PROD. DE ESPEC. FARMACEUT.S.A.

Therapeutic group:

PRAVASTATIN

Therapeutic indications:

Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *Primary prevention of coronary events: In hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - Reduce the risk of myocardial infarcton. - Reduce the risk for revascularization. - Reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *Secondary prevention of cardiovascular events: Atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior MI Pravastatin is indicated to: - Slow the progression of coronary atherosclerosis. - Reduce the risk of acute coronary events. Myocardial infa

Authorization date:

2013-05-01